A three-component one-pot synthesis of 2-alkoxy-4-amino-N-arylthiazole-5-carboxamides
文献类型:期刊论文
作者 | Zhao HaiLong2; Zhou Jie2; Song HongRui1; Xu BaiLing2 |
刊名 | CHINESE CHEMICAL LETTERS |
出版日期 | 2014 |
卷号 | 25期号:3页码:411-414 |
ISSN号 | 1001-8417 |
关键词 | HUMAN PIN1 INHIBITORS BIOLOGICAL EVALUATION DERIVATIVES AGENTS 4-Aminothiazole-5-carboxamide Potassium methyl cyanimidodithiocarbonate Acetamide |
其他题名 | A three-component one-pot synthesis of 2-alkoxy-4-amino-N-arylthiazole-5-carboxamides |
英文摘要 | A facile and efficient protocol was developed to access 2-alkoxy-4-amino-N-aryithiazole-5-carboxamides through a three-component one-pot reaction, which involved potassium methyl cyanimidodithiocarbonate, 2-halo-N-arylacetamides and alcohols. The easy availability and the broad structural diversity of substrates make the reaction useful for the construction of libraries in drug discovery. (C) 2013 Bai-Ling Xu. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved. |
资助项目 | [National Natural Science Foundation of China] ; ["863" Program of China] |
语种 | 英语 |
CSCD记录号 | CSCD:5069001 |
源URL | [http://ir.imr.ac.cn/handle/321006/142702] |
专题 | 金属研究所_中国科学院金属研究所 |
作者单位 | 1.中国科学院金属研究所 2.Chinese Acad Med Sci, Institute Mat Med, Beijing Key Lab Act Subst Discovery & Drug Evalua, Beijing 100050, Peoples R China Institute Mat Med Beijing Key Lab Act Subst Discovery & Drug Evalua 3.Peking Union Med Coll, Beijing 100050, Peoples R China |
推荐引用方式 GB/T 7714 | Zhao HaiLong,Zhou Jie,Song HongRui,et al. A three-component one-pot synthesis of 2-alkoxy-4-amino-N-arylthiazole-5-carboxamides[J]. CHINESE CHEMICAL LETTERS,2014,25(3):411-414. |
APA | Zhao HaiLong,Zhou Jie,Song HongRui,&Xu BaiLing.(2014).A three-component one-pot synthesis of 2-alkoxy-4-amino-N-arylthiazole-5-carboxamides.CHINESE CHEMICAL LETTERS,25(3),411-414. |
MLA | Zhao HaiLong,et al."A three-component one-pot synthesis of 2-alkoxy-4-amino-N-arylthiazole-5-carboxamides".CHINESE CHEMICAL LETTERS 25.3(2014):411-414. |
入库方式: OAI收割
来源:金属研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。